4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000223
Director sold 28,000 shares at an average $57.58 ($1,612,155)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WENDER JOSEPH H · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-02 | Sale : show line 1 in the form 10b5-1 | −11,200 | $55.04 | $616,432 | 125,635 | I |
| 2025-09-02 | Sale : show line 2 in the form 10b5-1 | −5,600 | $57.53 | $322,174 | 120,035 | I |
| 2025-09-03 | Sale : show line 3 in the form 10b5-1 | −11,200 | $60.14 | $673,549 | 108,835 | I |
| Open-market sales · 28,000 sh · avg $57.58 · $1,612,155 | ||||||
Loading xslF345X05/edgardoc.xml…